About
Technology
Issues
FAQ
Links
Official Page
F108. CONCURRENT USAGE OF SUBLINGUAL OXYTOCIN AND CLOZAPINE TO TREAT THE POSITIVE AND NEGATIVE SYMPTOMS WITHIN INDIVIDUALS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
site/software ©
exaly
; All materials licenced under
CC by-SA
.